Keyphrases
Colorectal Cancer
82%
Hereditary Colorectal Cancer Syndromes
62%
Lynch Syndrome
60%
Cancer Types
55%
Confidence Interval
39%
Incidence Rate
38%
Familial Colorectal Cancer Type X (FCCTX)
38%
Odds Ratio
35%
Age-specific Incidence
33%
Risk Estimation
33%
Comorbidity
27%
Nurse Practitioner Practice
27%
Multiple Colorectal Cancers
27%
Hereditary Predisposition
27%
Invasive Pneumococcal Disease
27%
Gender-based
27%
Postoperative Complications
27%
Risk Profile
27%
Free Text
27%
Gene-based
27%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
27%
Cancer Subgroups
27%
Risk Markers
27%
Noncardiac Surgery
27%
Cancer Development
27%
Early Warning Scoring
27%
National Surveillance
27%
Amsterdam
22%
Moderate Risk
22%
Cancer Register
17%
Colorectal Cancer Risk
16%
Advanced Adenoma
16%
Increased Incidence
13%
Tumor Subtype
13%
Breast Cancer
13%
Cancer Tumor
13%
Urothelial Cancer
12%
Gastric Cancer
12%
Mismatch Repair
12%
Pancreatic Cancer
12%
Sex-specific
12%
CRC Colorectal Cancer
11%
X-family
11%
Primary Colorectal Cancer
11%
Second Primary
11%
Metachronous
11%
Surveillance Colonoscopy
11%
Surveillance Program
11%
Vital Parameters
9%
Airway
9%
Medicine and Dentistry
Colorectal Cancer
100%
Hereditary Colorectal Cancer
68%
Hereditary Nonpolyposis Colorectal Cancer
65%
Cancer Types
63%
Odds Ratio
35%
Meningococcal Disease
27%
Urokinase Receptor
27%
Noncardiac Surgery
27%
Postoperative Complication
27%
Disease Predisposition
27%
Malignant Neoplasm
19%
Adenoma
15%
Cancer Registry
12%
Colonoscopy
11%
Neoplasm
11%
Stomach Cancer
8%
Disease
8%
Urothelial Cancer
8%
Breast Cancer
8%
DNA Mismatch Repair
8%
Pancreas Cancer
8%
Anesthesiologist
8%
Observational Study
6%
Solid Organ Transplantation
5%
Liver Disease
5%
Serotype
5%
Kidney Cancer
5%
Nephropathy
5%
C Reactive Protein
5%
Brain Tumor
5%
Cancer Cell
5%
Colorectal Tumor
5%
Cancer Syndrome
5%
Cohort Analysis
5%
Population
5%
Endometrial Cancer
5%
Skin Tumor
5%
Intestine Cancer
5%
Cancer
5%
Ovarian Cancer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
74%
Hereditary Colorectal Cancer
55%
Malignant Neoplasm
55%
Hereditary Nonpolyposis Colorectal Cancer
43%
Urokinase Receptor
27%
Postoperative Complication
27%
Adenoma
15%
Neoplasm
11%
Stomach Cancer
9%
Disease
9%
Breast Cancer
9%
Pancreas Cancer
9%
Observational Study
6%
Skin Tumor
5%
Colorectal Tumor
5%
Intestine Cancer
5%
Endometrium Cancer
5%
Brain Tumor
5%
Tumor Syndrome
5%
Cohort Study
5%
Ovary Cancer
5%
C Reactive Protein
5%
